Genovate Biotechnology Financials
| 4130 Stock | TWD 21.65 0.10 0.46% |
Genovate |
Understanding current and past Genovate Biotechnology Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Genovate Biotechnology's financial statements are interrelated, with each one affecting the others. For example, an increase in Genovate Biotechnology's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Genovate Biotechnology's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Genovate Biotechnology Co. Check Genovate Biotechnology's Beneish M Score to see the likelihood of Genovate Biotechnology's management manipulating its earnings.
| Instrument | Taiwan Stock View All |
| Exchange | Taiwan OTC Exchange |
| ISIN | TW0004130000 |
| Business Address | No 1, Gongye |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.genovate-bio.com |
| Phone | 886 3 598 2221 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in Genovate Biotechnology without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Genovate Stock, because this is throwing your money away. Analyzing the key information contained in Genovate Biotechnology's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Genovate Biotechnology Key Financial Ratios
There are many critical financial ratios that Genovate Biotechnology's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Genovate Biotechnology reports annually and quarterly.| Return On Equity | 0.0022 | |||
| Return On Asset | 0.0015 | |||
| Number Of Employees | 181 | |||
| Beta | 0.21 | |||
| Last Dividend Paid | 0.35 |
Genovate Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Genovate Biotechnology's current stock value. Our valuation model uses many indicators to compare Genovate Biotechnology value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Genovate Biotechnology competition to find correlations between indicators driving Genovate Biotechnology's intrinsic value. More Info.Genovate Biotechnology Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.68 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Genovate Biotechnology Co is roughly 1.47 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Genovate Biotechnology's earnings, one of the primary drivers of an investment's value.Genovate Biotechnology Systematic Risk
Genovate Biotechnology's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Genovate Biotechnology volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourty-two with a total number of output elements of nineteen. The Beta measures systematic risk based on how returns on Genovate Biotechnology correlated with the market. If Beta is less than 0 Genovate Biotechnology generally moves in the opposite direction as compared to the market. If Genovate Biotechnology Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Genovate Biotechnology is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Genovate Biotechnology is generally in the same direction as the market. If Beta > 1 Genovate Biotechnology moves generally in the same direction as, but more than the movement of the benchmark.
Genovate Biotechnology Thematic Clasifications
Genovate Biotechnology Co is part of several thematic ideas from Biotech to IT. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasGenovate Biotechnology December 12, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Genovate Biotechnology help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Genovate Biotechnology Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Genovate Biotechnology Co based on widely used predictive technical indicators. In general, we focus on analyzing Genovate Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Genovate Biotechnology's daily price indicators and compare them against related drivers.
| Downside Deviation | 0.7568 | |||
| Information Ratio | (0.17) | |||
| Maximum Drawdown | 2.91 | |||
| Value At Risk | (1.32) | |||
| Potential Upside | 1.31 |
Additional Tools for Genovate Stock Analysis
When running Genovate Biotechnology's price analysis, check to measure Genovate Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genovate Biotechnology is operating at the current time. Most of Genovate Biotechnology's value examination focuses on studying past and present price action to predict the probability of Genovate Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genovate Biotechnology's price. Additionally, you may evaluate how the addition of Genovate Biotechnology to your portfolios can decrease your overall portfolio volatility.